Provided by Tiger Trade Technology Pte. Ltd.

KraneShares MSCI All China Health Care Index ETF

18.34
+0.59943.38%
Volume:17.60K
Turnover:321.78K
Market Cap:108.21M
PE:- -
High:18.34
Open:18.31
Low:18.11
Close:17.74
52wk High:21.50
52wk Low:14.38
Shares:5.90M
Float Shares:5.90M
Volume Ratio:0.55
T/O Rate:0.30%
Dividend:0.71
Dividend Rate:3.90%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Hong Kong Stocks Recover as WCLC Conference Sparks Biotech Rally, While US AI Slowdown Calls Raise Questions

Stock News
·
Yesterday

Southbound Capital Flow: Net Buying Reaches HK$4.471 Billion, with Heavy Inflows into AI Hardware Stocks and Z.AI (02513) Attracting Over HK$1.2 Billion

Stock News
·
Yesterday

CSPC Pharmaceutical Group Stock Rallies 1.8% in Hong Kong

Dow Jones
·
Yesterday

Wuxi Biologics (Cayman) Stock Advances 4.6% in Hong Kong

Dow Jones
·
Yesterday

JPMorgan Highlights Strong Overall Survival Data from Akeso's HARMONi-2 Trial, Reaffirms Overweight Rating

Stock News
·
Yesterday

Big Pharma is Pouring Billions into China's Biotechs

Dow Jones
·
Yesterday

Innovent's Enlarged Cash Holdings, Investment Fair Value Could Boost Earnings

Dow Jones
·
Yesterday

Citi Highlights Akeso's HARMONi-2 Overall Survival Edge, Reaffirming Buy Rating on Differentiation

Stock News
·
Yesterday

HK Stocks in Focus: Innovative Drug Sector Surges on WCLC Data Boost, Analysts See Value After Pullback

Stock News
·
Yesterday

Hong Kong Market Update | CRO Stocks Lead Gains as Interim Results Reinforce Sector Momentum, Multiple Firms Lift Guidance

Stock News
·
Yesterday

AKESO Shares Climb After WCLC Data Highlights OS Benefit of Lead Drug Versus Keytruda

Deep News
·
Yesterday

Goldman Sachs Sees Clear Recovery in China's CRO/CDMO Sector, Favorable on WuXi-Linked Stocks

Stock News
·
Yesterday

Akeso Says Phase III HARMONi-2 Trial Shows Ivonescimab Lifts Overall Survival vs Pembrolizumab in PD-L1-Positive NSCLC

Reuters
·
Sep 13

HK Stock Market Update | Innovative Drug Stocks Face Continued Pullback Amid Shifting Overseas Rate Expectations and Post-2026 Negotiation Uncertainty

Stock News
·
Sep 11

Wuxi Biologics (Cayman) Stock Slips 2.7% in Hong Kong

Dow Jones
·
Sep 10

CSPC Pharmaceutical Group Stock Slips 3.6% in Hong Kong, Underperforms Competitors

Dow Jones
·
Sep 10

Global Equities Roundup: Market Talk

Dow Jones
·
Sep 10

Hong Kong Market Flash | CSPC Pharma Drops Over 4% as Lp(a) HORIZON Study Setback May Pressure Participants Including the Company

Stock News
·
Sep 10

CSPC Pharma's Clinical Data Presentations Could be Near-Term Share Catalysts

Dow Jones
·
Sep 10

WuXi Biologics Files HKEX Next-Day Disclosure, Share Capital Rises by 1.2 Million Shares

Reuters
·
Sep 09